Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk (Q46386883)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk |
scientific article |
Statements
1 reference
Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Thomas Illig
1 reference
Carolin Strobl
1 reference
Norman Klopp
1 reference
H-Erich Wichmann
1 reference
Natalija Novak
1 reference
Elke Rodriguez
1 reference
Stefan Wagenpfeil
1 reference
Johannes Ring
1 reference
Heidrun Behrendt
1 reference
Thomas Bieber
1 reference
Jonathan N W N Barker
1 reference
Simon Meggitt
1 reference
Aileen Sandilands
1 reference
Haihui Liao
1 reference
Grainne M O'Regan
1 reference
Rosemarie Watson
1 reference
John Henderson
1 reference
Huijia Chen
1 reference
Yiwei Zhao
1 reference
Michael Allen
1 reference
Caroline Stahl
1 reference
Thomas Kneib
1 reference
1 September 2008
1 reference
122
1 reference
3
1 reference
560-8.e4
1 reference
Identifiers
1 reference